Results 31 to 40 of about 104,217 (332)

Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination

open access: yesNature Communications, 2019
Oligodendrocyte precursor cells (OPCs) are abundant in the adult central nervous system, and have the capacity to regenerate oligodendrocytes and myelin. However, in inflammatory diseases such as multiple sclerosis (MS) remyelination is often incomplete.
L. Kirby   +14 more
semanticscholar   +1 more source

CHARACTERIZATION OF SIGNAL CONDUCTION ALONG DEMYELINATED AXONS BY ACTION-POTENTIAL-ENCODED SECOND HARMONIC GENERATION [PDF]

open access: yesJournal of Innovative Optical Health Sciences, 2014
Action-potential-encoded optical second harmonic generation (SHG) has been recently proposed for use in detecting the axonal damage in patients with demyelinating diseases.
ZHI-HUI LUO   +6 more
doaj   +1 more source

Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis

open access: yesActa Neuropathologica, 2020
Axonal loss is the key pathological substrate of neurological disability in demyelinating disorders, including multiple sclerosis (MS). However, the consequences of demyelination on neuronal and axonal biology are poorly understood.
Simon Licht-Mayer   +36 more
semanticscholar   +1 more source

Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination

open access: goldFrontiers in Cellular Neuroscience, 2019
CD38 is an enzyme that catalyzes the synthesis of cyclic adenosine diphosphate-ribose from nicotinamide adenine dinucleotide (NAD+). We recently reported that this molecule regulates the maturation and differentiation of glial cells such as astrocytes ...
Jureepon Roboon   +12 more
openalex   +2 more sources

Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2020
Significance Microglia are the resident phagocytic cells of the central nervous system (CNS). During demyelination, a condition in which myelin sheaths are damaged and removed from neurons due to inflammation, microglia can play both harmful and ...
A. Sariol   +9 more
semanticscholar   +1 more source

Central Pontine Myelinosis and Osmotic Demyelination Syndrome.

open access: yesDeutsches Ärzteblatt International, 2019
BACKGROUND Osmotic demyelination syndrome (ODS), which embraces central pontine myelinolysis (CPM) and extrapontine myelinosis (EPM), is often underdiagnosed in clinical practice, but can be fatal.
J. Lambeck   +3 more
semanticscholar   +1 more source

Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine

open access: yesMolecular Pain, 2010
Background Although neuropathic pain is frequently observed in demyelinating diseases such as Guillain-Barré syndrome and multiple sclerosis, the molecular basis for the relationship between demyelination and neuropathic pain behaviors is poorly ...
Aoki Junken   +8 more
doaj   +1 more source

Secondary parkinsonism due to osmotic demyelination syndrome: a case report

open access: yesThe Egyptian Journal of Internal Medicine, 2015
Hyponatremia is a common medical problem often found in the elderly and is due to poor intake, medical comorbidities, and medications. Central to the management of this condition is the use of normal and hypertonic saline, besides the use of ...
Waseem R Dar   +4 more
doaj   +1 more source

Clinical manifestations and imaging features of white matter demyelination in older patients

open access: yesJournal of International Medical Research, 2020
Objective To investigate the clinical manifestations and imaging features of older patients with white matter demyelination diagnosed by magnetic resonance imaging (MRI).
Jian Li, Yi-Ming Zhao
doaj   +1 more source

CNS Demyelination with TNF-α Blockers

open access: yesCurrent Neurology and Neuroscience Reports, 2017
Tumor necrosis factor–α (TNF-α) blockers are a popular therapeutic choice in a number of inflammatory diseases. Thus far, five TNF- α blockers have been approved for clinical use (etanercept, infliximab, adalimumab, golimumab. and certolizumab).
E. Kemanetzoglou, E. Andreadou
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy